Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials.

Author: AbbasowaLeda, KessingLars V, VinbergMaj

Paper Details 
Original Abstract of the Article :
Despite antidepressant therapy of appropriate trial duration and dose optimization, 50-60% of depressed patients have an adequate treatment response, whereas only 35-40% achieve remission. Psychostimulants have been suggested as potential candidates to promote acceleration of response and to allevia...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.3109/08039488.2012.752035

データ提供:米国国立医学図書館(NLM)

Psychostimulants in Moderate to Severe Affective Disorder: A Systematic Review of Randomized Controlled Trials

Depression, a prevalent mental health disorder, often requires long-term treatment and management. This research explores the potential of psychostimulants, medications that stimulate the central nervous system, as a treatment option for moderate to severe depression. The study, a systematic review of randomized controlled trials, examined the evidence for the use of psychostimulants in depression. The findings suggest that psychostimulants may be beneficial in promoting a faster response to antidepressant treatment and alleviating residual symptoms of depression, offering a potential new avenue for managing this challenging condition.

Unlocking the Potential of Psychostimulants in Depression Treatment

This research, like a desert expedition uncovering hidden treasures, reveals the potential of psychostimulants in the treatment of depression. The findings, similar to a map revealing a hidden oasis in the desert, provide valuable insights into the effectiveness of psychostimulants in promoting a faster response to antidepressant treatment.

Navigating the Desert of Depression Treatment: Psychostimulants

Imagine a desert traveler seeking a faster route to their destination. Psychostimulants, like a shortcut through the desert, offer a potential pathway to faster response and symptom relief for individuals struggling with depression. This research provides valuable information about the potential benefits of psychostimulants, encouraging further exploration of this treatment option.

Dr. Camel's Conclusion

This research, like a compass guiding us through the vast desert of depression treatment, explores the potential of psychostimulants as a valuable tool for managing this complex condition. The findings encourage further exploration of this treatment option, offering hope for a more effective and efficient approach to addressing the challenges of depression.

Date :
  1. Date Completed 2014-10-20
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

23293898

DOI: Digital Object Identifier

10.3109/08039488.2012.752035

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.